Latanoprost NDC# 82187-1002-1 Container Description: Amber colour… — Class II drug recall D-0264-2025
Ongoing recall by Aspen Biopharma Labs Pvt., Ltd., reported 2025-03-19, distributed in FL. CGMP Deviations
| Recall number | D-0264-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aspen Biopharma Labs Pvt., Ltd., Medchal Malkajgiri, India |
| Recall initiated | 2025-02-07 |
| Classified | 2025-03-09 |
| Reported by FDA | 2025-03-19 |
| Distributed | FL |
| Countries outside the US | HK |
| Quantity | 150 gm |
| Reason classes | cgmp |
| NDC | 82187-1002-01 |
| Lot numbers | AUG-2027, DEC-2026, HALAC0010123, HALAC0050923 |
Product
Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0264-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.